Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Most protocols run 8-12 weeks, followed by 4-8 weeks off
Common Mistakes to Avoid Injection administration errors frequently lead to denials, audits, and lost revenue
Research Snapshot HGF/c-Met Pathway: Dihexa is primarily investigated for its ability to potentiate Hepatocyte Growth Factor (HGF) signaling through the c-Met receptor, a pathway involved in neuronal survival, synapse formation, and dendritic spine growth
Frequently Asked Questions References [1] [2] National Library of Medicine, Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing, Gwyer, D., Wragg, N., Wilson, S., 2017 [3] [5] National Library of Medicine, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, Vasireddi, N., Hahamyan, H., Salata, M., Karns, M., Calcei, J., Voos, J., Apostolakos, J., July 2025 [4] National Library of Medicine, Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway, Hsieh, M., Lee, C., Cheh, H., Chang, G, Huang, H., Lin, Y., Pang, J., October, 2020
Immunohistological study of isoantigens, carcinoembryonic antigen and hCG in [PMID: 6715926] Laboratory literature summary: Immunohistological study of isoantigens, carcinoembryonic antigen and hCG in adenocarcinomas of the uterus
In conclusion, this manuscript tried to prove the therapeutic effects of BPC 157 in spinal cord injury using a rat model
